In all likelihood, we predict that commonly occurring polymorphic variants of Zn transporters, including but not limited to ZIP8 and ZIP14, have the potential to increase susceptibility to infection by adversely altering Zn metabolism during the acute-phase response and thereby altering cellular defense mechanisms in myeloid and other parenchymal cell types. Here, SLC39A14 is linked to infection.